O'Keefe Kenneth W 4
4 · Jazz Pharmaceuticals plc · Filed Mar 9, 2023
Insider Transaction Report
Form 4
O'Keefe Kenneth W
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2023-03-07$81.76/sh+4,500$367,920→ 25,579 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-03-07−4,500→ 0 totalExercise: $81.76Exp: 2013-08-07→ Ordinary Shares (4,500 underlying) - Sale
Ordinary Shares
2023-03-07$138.39/sh−2,690$372,267→ 22,889 total
Holdings
- 4,445(indirect: By Trust)
Ordinary Shares
Footnotes (3)
- [F1]Shares sold to pay option price from the exercise of stock options.
- [F2]Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
- [F3]This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. This option vested in 12 equal monthly installments beginning on September 1, 2013.